Please login or register to print this page.

ARTICLE CONTRIBUTORS

National Institute for Health and Clinical Excellence

Clinical Articles, Featured

NICE updates evidence on VTE risk

Improved understanding of venous thromboembolism (VTE) and the best interventions for it are the focus of the latest Evidence Update1 from NHS Evidence. The update summarises new data relevant to National Institute for Health and Clinical Excellence (NICE) clinical guideline 92.

In producing the Evidence Update, more than 2,000 pieces of evidence were searched of which 25 have been chosen for publication. An Evidence Update Advisory Group, comprised of subject experts, has reviewed the prioritised evidence and provided a commentary.

Dr Mike Durkin, National Clinical Director for VTE said, “I am delighted to welcome this Evidence Update from NICE as an important contribution to our National VTE Prevention Programme in England.

“It is important to recognise the evidence that has emerged since the publication of the NICE clinical guideline CG92: ‘Reducing the risk of VTE in patients admitted to hospital’ (2010) and I would like to acknowledge the clinical experts who have contributed to this Evidence Update led by Professor Tom Quinn.

VTE risk - Gerard Stansby1

Professor Gerard Stansby

“It is national policy in England that all adults receive a risk assessment for VTE in order to reduce the risk of them developing a blood clot after admission to hospital. This Evidence Update from NICE will help improve our clinical understanding of the most appropriate and effective interventions so that we can continue to save lives and reduce long term disability from VTE.”

Advisory Group member Professor Gerard Stansby (Freeman Hospital, Newcastle upon Tyne) told BJC Arrhythmia Watch: “VTE is a major cause of mortality and morbidity in the NHS and its prevention has recently been made an NHS Priority by Sir Bruce Keogh. In 2010 NICE issued a clinical guideline (CG 92) “Reducing the risk of venous thromboembolism” based on a thorough review of the evidence available at the time.

“Inevitably new data has subsequently emerged. Now this evidence base has been updated and critically evaluated by NHS Evidence with the help of a team of clinical experts.  This update does not replace CG 92 but does supplement it and should help increase awareness of new developments in the field. Key messages are highlighted as well as areas where more data is required.  It should add significantly to clinicians’ ability to deliver effective and appropriate interventions for VTE”.

References

1. Venous thromboembolism: reducing the risk, Evidence Update February 2012. Available at www.evidence.nhs.uk/evidence-update-6.

Published on: March 9, 2012

Members Area

Log in or Register now.

 For healthcare professionals only
Learning sky

SEARCH THE SITE

RSS FEED

Subscribe to our RSS feed
home

GET EXCLUSIVE UPDATES

Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.

RECENT COMMENTS

    None Found

PROUDLY SPONSORED BY

Pifzer Pifzer

ENDORSED BY

  • Arrhythmia Alliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association
Medtronic
Medtronic
 

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.